A model for decoding resistance in precision oncology: acquired resistance to FGFR inhibitors in cholangiocarcinomaL. GoyalD. DiToroet al.2025Annals of Oncology
Developmental mosaicism underlying EGFR-mutant lung cancer presenting with multiple primary tumorsRisa BurrIgnaty Leshchineret al.2024Nat. Cancer
Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA MutationsAndreas VarkarisFerran Fece de la Cruzet al.2023Cancer Discovery